J Song1, Z Jin1, H Han1, M Li2, Y Guo1, H Guo3, W Guo1, J He1. 1. Department of Health Statistics, Second Military Medical University, Shanghai, China. 2. State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of Preventive Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China. 3. Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Abstract
AIM: The association between the use of oral contraceptives and hormone replacement therapy (HRT) or other reproductive factors and the risk of colorectal adenoma (CRA) remains controversial. Our study aimed to review the evidence by conducting a dose-response meta-analysis to investigate this association. METHODS: We searched PubMed and Embase databases for relevant studies published until May 2017. Traditional and dose-response meta-analyses were conducted. Sensitivity analysis was performed to evaluate the robustness of the results. Cumulative meta-analysis was used to assess the risk of different oral contraceptive formulations or generations. RESULTS: A total of 19 observational studies, with 21 923 CRA cases and 1 030 711 participants, were included in the meta-analysis. Ever HRT use showed a potential inverse association with CRA risk [relative risk (RR) 0.83, 95% CI 0.70-1.00]. The dose-response meta-analysis further demonstrated that HRT use could reduce CRA risk. Compared with no HRT use, the predicted RRs were 0.82 (95% CI 0.67-0.99), 0.76 (95% CI 0.59-0.98) and 0.77 (95% CI 0.62-0.96) for 3, 6 and 9 years of HRT use, respectively. All other factors were not statistically significantly associated with CRA risk. CONCLUSIONS: This study indicated that only HRT use might reduce the risk of developing CRA. Any advice regarding HRT use to prevent CRA should be tailored to the individual risks and potential benefits. Large, well-designed prospective studies with long-term follow-up are required to further clarify the aetiology of CRA. Colorectal Disease
AIM: The association between the use of oral contraceptives and hormone replacement therapy (HRT) or other reproductive factors and the risk of colorectal adenoma (CRA) remains controversial. Our study aimed to review the evidence by conducting a dose-response meta-analysis to investigate this association. METHODS: We searched PubMed and Embase databases for relevant studies published until May 2017. Traditional and dose-response meta-analyses were conducted. Sensitivity analysis was performed to evaluate the robustness of the results. Cumulative meta-analysis was used to assess the risk of different oral contraceptive formulations or generations. RESULTS: A total of 19 observational studies, with 21 923 CRA cases and 1 030 711 participants, were included in the meta-analysis. Ever HRT use showed a potential inverse association with CRA risk [relative risk (RR) 0.83, 95% CI 0.70-1.00]. The dose-response meta-analysis further demonstrated that HRT use could reduce CRA risk. Compared with no HRT use, the predicted RRs were 0.82 (95% CI 0.67-0.99), 0.76 (95% CI 0.59-0.98) and 0.77 (95% CI 0.62-0.96) for 3, 6 and 9 years of HRT use, respectively. All other factors were not statistically significantly associated with CRA risk. CONCLUSIONS: This study indicated that only HRT use might reduce the risk of developing CRA. Any advice regarding HRT use to prevent CRA should be tailored to the individual risks and potential benefits. Large, well-designed prospective studies with long-term follow-up are required to further clarify the aetiology of CRA. Colorectal Disease
Authors: Dong Hang; Xiaosheng He; Ane Sørlie Kværner; Andrew T Chan; Kana Wu; Shuji Ogino; Zhibin Hu; Hongbing Shen; Edward L Giovannucci; Mingyang Song Journal: BMC Med Date: 2021-01-28 Impact factor: 8.775
Authors: Yonghoon Choi; Nayoung Kim; Ki Wook Kim; Hyeong Ho Jo; Jaehyung Park; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyeon Jeong Oh; Hye Seung Lee; Young Suk Park; Sang-Hoon Ahn; Yun-Suhk Suh; Do Joong Park; Hyung-Ho Kim; Ji-Won Kim; Jin Won Kim; Keun-Wook Lee; Won Chang; Ji Hoon Park; Yoon Jin Lee; Kyoung Ho Lee; Young Hoon Kim Journal: World J Gastroenterol Date: 2022-03-07 Impact factor: 5.742
Authors: Úna C McMenamin; Peipei Liu; Andrew T Kunzmann; Michael B Cook; Helen G Coleman; Brian T Johnston; Marie M Cantwell; Chris R Cardwell Journal: Am J Gastroenterol Date: 2021-03-01 Impact factor: 12.045